Skip to main content

Goldman Sachs Sticks to Its Sell Rating for Bruker (BRKR)

Tipranks - Sat Feb 14, 7:14AM CST

In a report released today, from Goldman Sachs maintained a Sell rating on Bruker, with a price target of $35.00.

Valentine's Day Sale - 70% Off

Currently, the analyst consensus on Bruker is a Moderate Buy with an average price target of $51.36.

Based on Bruker’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $860.5 million and a GAAP net loss of $59.6 million. In comparison, last year the company earned a revenue of $864.4 million and had a net profit of $40.9 million

Based on the recent corporate insider activity of 36 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BRKR in relation to earlier this year. Most recently, in December 2025, Richard Packer, a Director at BRKR sold 5,028.00 shares for a total of $243,204.36.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.